Kilpatrick Townsend


Insights: Publications A Gene-Editing Patent Dispute – What Does It Mean? USF School of Law Intellectual Property and Technology Law Journal March 28, 2017 Is this just another ordinary patent dispute? Time will tell. A high profile patent dispute between the University of California, Berkeley and the Broad Institute of MIT and Harvard has just concluded a year-long proceeding called interference proceeding at US Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB). On February 15, 2017, PTAB announced its decision after both parties presented their oral arguments before a three-judge panel in December 2016. The proceeding was to determine which party has actually “invented” a gene-editing technology called CRISPR-cas9.

Insights: Publications

A Gene-Editing Patent Dispute – What Does It Mean?

USF School of Law Intellectual Property and Technology Law Journal

March 28, 2017

Is this just another ordinary patent dispute? Time will tell. A high profile patent dispute between the University of California, Berkeley and the Broad Institute of MIT and Harvard has just concluded a year-long proceeding called interference proceeding at US Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB). On February 15, 2017, PTAB announced its decision after both parties presented their oral arguments before a three-judge panel in December 2016. The proceeding was to determine which party has actually “invented” a gene-editing technology called CRISPR-cas9.